Cosmetovigilance of color cosmetics using openFDA: An adverse event atlas and disproportionality-based safety signals
Journal of Dermatologic Science and Cosmetic Technology
image: Cosmetovigilance of color cosmetics using openFDA: An adverse event atlas and disproportionality-based safety signals
Credit: Department of Dermatology, The First Affiliated Hospital of Xi’an Medical University, Xi'an 710000, China
This study examined adverse event patterns associated with eye, lip, and face color cosmetics using the openFDA cosmetic adverse event dataset. Among 85,511 reports, 619 met the inclusion criteria. Researchers constructed category–reaction heatmaps and bipartite networks to visualize reporting patterns, then calculated reporting odds ratios within 599 single-category reports, comparing each category with the other two. Overall, 54 category–reaction pairs met the predefined signal criteria. Eye products showed signals for ocular hyperaemia, eye infection, and eye irritation; lip products for oral discomfort, lip swelling, and cheilitis; and face products for urticaria, rash, and erythema. Sensitivity analyses addressing report version, report type, and the 2019 reporting spike showed directionally stable key signals. The study demonstrates how public regulatory reports can be transformed into an interpretable safety atlas to guide further investigation. These findings support hypothesis generation and targeted cosmetovigilance but cannot determine reaction incidence, quantify absolute risk, or establish causal relationships.
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.